KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Repay Holdings (RPAY) Operating Income (2017 - 2025)

Repay Holdings has reported Operating Income over the past 9 years, most recently at -$3.0 million for Q3 2025.

  • Quarterly results put Operating Income at -$3.0 million for Q3 2025, down 345.78% from a year ago — trailing twelve months through Sep 2025 was -$112.7 million (down 32.49% YoY), and the annual figure for FY2024 was -$7.8 million, up 93.03%.
  • Operating Income for Q3 2025 was -$3.0 million at Repay Holdings, up from -$104.9 million in the prior quarter.
  • Over the last five years, Operating Income for RPAY hit a ceiling of -$675000.0 in Q3 2024 and a floor of -$104.9 million in Q2 2025.
  • Median Operating Income over the past 5 years was -$8.8 million (2021), compared with a mean of -$17.5 million.
  • Biggest five-year swings in Operating Income: skyrocketed 98.51% in 2024 and later tumbled 2966.47% in 2025.
  • Repay Holdings' Operating Income stood at -$20.7 million in 2021, then increased by 11.47% to -$18.3 million in 2022, then crashed by 328.94% to -$78.5 million in 2023, then skyrocketed by 98.51% to -$1.2 million in 2024, then plummeted by 157.18% to -$3.0 million in 2025.
  • The last three reported values for Operating Income were -$3.0 million (Q3 2025), -$104.9 million (Q2 2025), and -$3.6 million (Q1 2025) per Business Quant data.